Daxor Corporation (DXR)
Largest Insider Buys in Sector
DXR Stock Price History Chart
DXR Stock Performance
About Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Insider Activity of Daxor Corporation
Over the last 12 months, insiders at Daxor Corporation have bought $41,766 and sold $0 worth of Daxor Corporation stock.
On average, over the past 5 years, insiders at Daxor Corporation have bought $52,606 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Michel Robert J (Chief Financial Officer) — $17,330. Feldschuh Michael Richard (CHIEF EXECUTIVE OFFICER) — $17,226. Feuer Edward (director) — $7,210.
The last purchase of 750 shares for transaction amount of $6,525 was made by Michel Robert J (Chief Financial Officer) on 2024‑03‑27.
List of Insider Buy and Sell Transactions, Daxor Corporation
| 2024-03-27 | Michel Robert J | Chief Financial Officer | 750 0.0161% | $8.70 | $6,525 | +11.38% | ||
| 2024-03-04 | Feuer Edward | director | 1,000 0.0212% | $7.21 | $7,210 | +30.18% | ||
| 2023-12-06 | Michel Robert J | Chief Financial Officer | 120 0.0025% | $7.75 | $930 | +14.71% | ||
| 2023-12-01 | Feldschuh Michael Richard | Chief Executive Officer | 800 0.0166% | $7.80 | $6,240 | +13.18% | ||
| 2023-12-01 | Michel Robert J | Chief Financial Officer | 180 0.0037% | $7.75 | $1,395 | +13.18% | ||
| 2023-11-24 | Michel Robert J | Chief Financial Officer | 500 0.0104% | $7.94 | $3,970 | +11.46% | ||
| 2023-11-10 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | 1,001 0.021% | $7.83 | $7,838 | +12.82% | ||
| 2023-11-09 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | 401 0.0082% | $7.85 | $3,148 | +10.23% | ||
| 2023-10-13 | Michel Robert J | Chief Financial Officer | 500 0.0106% | $9.02 | $4,510 | -1.79% | ||
| 2023-05-24 | Feldschuh Michael Richard | CEO & President | 2,000 0.0494% | $9.75 | $19,500 | -1.14% | ||
| 2023-05-24 | Goudie Joy S. | director | 300 0.0074% | $9.75 | $2,925 | -1.14% | ||
| 2022-11-18 | Michel Robert J | Chief Financial Officer | 1,000 0.025% | $10.00 | $10,000 | -3.23% | ||
| 2022-11-17 | DesRosiers Caleb | director | 3,157 0.0745% | $9.50 | $29,992 | -3.81% | ||
| 2021-04-19 | Michel Robert J | CHIEF FINANCIAL OFFICER | 1,000 0.0245% | $10.25 | $10,250 | +5.22% | ||
| 2021-04-16 | Feldschuh Michael Richard | CEO & President | 4,200 0.1033% | $10.33 | $43,386 | +4.47% | ||
| 2019-03-21 | Feldschuh Michael Richard | CEO & President | 1,200 0.0297% | $12.35 | $14,818 | -23.82% | ||
| 2018-11-07 | Michel Robert J | CHIEF FINANCIAL OFFICER | 3,250 0.0954% | $8.71 | $28,315 | +27.82% | ||
| 2018-07-31 | Thompson Soren | VP, Business Development | 1,000 0.0257% | $5.50 | $5,500 | +54.72% | ||
| 2018-07-13 | Feuer Edward | director | 1,500 0.0374% | $6.18 | $9,270 | +30.13% | ||
| 2018-03-15 | Sale | Feldschuh Michael Richard | President | 20,800 0.633% | $16.40 | $341,120 | -49.44% |
Insider Historical Profitability
| Feldschuh Michael Richard | Chief Executive Officer | 162492 3.4317% | $9.59 | 31 | 1 | +6.75% |
| Michel Robert J | Chief Financial Officer | 11300 0.2228% | $9.59 | 8 | 0 | +27.82% |
| Feuer Edward | director | 1000 0.0317% | $9.59 | 2 | 0 | +30.13% |
| FELDSCHUH JOSEPH | 10 percent owner | 2774455 58.5947% | $9.59 | 106 | 3 | +24.27% |
| Hudson Philip Nordan | director | 146200 3.0877% | $9.59 | 13 | 0 | |
| WILLENS ROBERT | director | 18164 0.3836% | $9.59 | 17 | 0 | +21.24% |
| WOLPOFF MARTIN S | director | 4000 0.0845% | $9.59 | 8 | 2 | +18.35% |
| Feldschuh Jonathan Adam | director | 3908 0.0825% | $9.59 | 0 | 1 | |
| DesRosiers Caleb | director | 3157 0.0667% | $9.59 | 1 | 0 | |
| Thompson Soren | VP, Business Development | 1950 0.0412% | $9.59 | 2 | 1 | +54.72% |
| MOUSSA ROBERT G | director | 1000 0.0211% | $9.59 | 2 | 0 | |
| Engstrom Everis | Vice President | 500 0.0106% | $9.59 | 1 | 0 | |
| LOMBARD JAMES A | director | 500 0.0106% | $9.59 | 2 | 0 | |
| Valentine Stephen | director | 500 0.0106% | $9.59 | 1 | 0 | |
| Meegan Diane Marie | Corporate Secretary | 500 0.0106% | $9.59 | 1 | 1 | |
| Goudie Joy S. | director | 300 0.0063% | $9.59 | 1 | 0 | |
| Saxe Bernhard | director | 200 0.0042% | $9.59 | 1 | 0 | |
| SLOVIN BRUCE | director | 0 0% | $9.59 | 0 | 6 |
Institutional Investor Ownership
| The Vanguard Group | $420,746.00 | 0.99 | 47,328 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $136,000.00 | 0.32 | 15,321 | 0% | +$0 | <0.0001 | |
| UBS | $10,312.00 | 0.02 | 1,160 | New | +$10,312.00 | <0.0001 | |
| Morgan Stanley | $1,556.00 | <0.01 | 175 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $42.00 | <0.01 | 5 | +25% | +$8.40 | <0.0001 |